Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt
Clinical & Experimental Ophthalmology · 2025
DOI: 10.1111/ceo.14578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2025. Verfasst von Zoe Pasvanis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Flavonols, Filtering Surgery, Cicatrix, Conjunctiva. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BrightFocus Foundation, University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship, Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program.
Abstract (Originalsprache)
Background
The success of minimally invasive bleb surgery (MIBS) such as the PreserFlo MicroShunt (PFMS) is limited by post‐operative bleb fibrosis. Current clinical practice prescribes the use of off‐label cytotoxic antimetabolites such as Mitomycin C (MMC) as antifibrotic therapy. This study investigates the anti‐scarring properties of a novel compound, 3′,4′‐Dihydroxyflavonol (DiOHF) in a rabbit model of PFMS filtration surgery.
Methods
Fifteen New Zealand white rabbits underwent unilateral MIBS with PFMS. Treatment was randomised to the following groups: (1) vehicle ( n = 5), (2) DiOHF ( n = 5), both applied three times daily for 2 weeks or (3) a single dose of MMC administered intraoperatively ( n = 5). Blebs were photographed post‐operatively on Days 0, 7 and 14 for clinical examination. Eyes were harvested on Day 14 and processed for immunohistochemical tissue staining to assess collagen deposition, expression of αSMA, oxidative stress, fibroblast activity, angiogenesis and inflammation in the conjunctiva/Tenon's layer.
Results
At 2‐weeks post‐surgery, MMC blebs were larger and more ischaemic than other treatments (Bleb size: MMC vs. DiOHF, p = 0.0098; MMC vs. vehicle, p = 0.0001. Ischaemia: p = 0.0004 for both). Compared to vehicle control, DiOHF blebs expressed decreased vimentin ( p = 0.0099), αSMA ( p = 0.0231) and 3‐nitrotyrosine ( p = 0.0410) after 2 weeks. DiOHF blebs expressed less CD45 than other treatments (DiOHF vs. Vehicle, p = 0.0013; DiOHF vs. MMC, p = 0.0232) and less collagen accumulation (DiOHF vs. vehicle, p = 0.0512). There was no difference in CD31 expression between treatment groups.
Conclusions
DiOHF inhibited scarring following implantation of PFMS in rabbit eyes by reducing local oxidative stress, inflammation and fibroblastic activity. DiOHF may be a safer and more effective wound modulating agent than the conventional use of MMC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
- Ophthalmology, Department of Surgery, University of Melbourne, Parkville, Victoria, Australia.
- Department of Medicine, St. Vincent's Hospital, University of Melbourne, Parkville, Victoria, Australia.
- Glaucoma Research and Investigation Unit, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
ORCID-Profile: Jennifer C Fan Gaskin
Förderung
- BrightFocus Foundation
- University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship
- Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program
- Australian Government Research Training Program (RTP) Scholarship
Zitieren
APA
Pasvanis, Z., Kong, R. C. K., Chan, E. C., & Fan Gaskin, J. C. (2025). Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14578
Vancouver
Pasvanis Z, Kong RCK, Chan EC, Fan Gaskin JC. Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt. Clinical & Experimental Ophthalmology. 2025. doi:10.1111/ceo.14578
BibTeX
@article{Pasvanis2025,
author = {Pasvanis, Zoe and Kong, Roy C K and Chan, Elsa C and Fan Gaskin, Jennifer C},
title = {Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt},
journal = {Clinical & Experimental Ophthalmology},
year = {2025},
doi = {10.1111/ceo.14578}
}
EUVIMED